作者：
Xuan,Yang [1]
;
Rebekah J,Dickmander [2]
;
Armin,Bayati [2]
;
Sharon A,Taft-Benz [3]
;
Jeffery L,Smith [4]
;
Carrow I,Wells [5]
;
Emily A,Madden [6]
;
Jason W,Brown [2]
;
Erik M,Lenarcic [7]
;
Boyd L,Yount [1]
;
Edcon,Chang [1]
;
Alison D,Axtman [7]
;
Ralph S,Baric [8]
;
Mark T,Heise [2]
;
Peter S,McPherson [3]
;
Nathaniel J,Moorman [4]
;
Timothy M,Willson [9]
作者单位：
Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[1]
Rapidly Emerging Antiviral Drug Development Initiative (READDI), Chapel Hill, North Carolina 27599, United States.
[2]
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[3]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[4]
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[5]
Structural Genomics Consortium, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada.
[6]
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[7]
Takeda San Diego, San Diego, California 92121, United States.
[8]
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
[9]
DOI
10.1021/acschembio.2c00378
PMID
35723434
发布时间
2022-11-05
换一批
换一批
